Share on LinkedInShare on LinkedIn

ARTICLE · 21 JULY 2026

Pharmacy Benefit Manager Reaches Settlement With FTC Requiring Changes To Drug Pricing And Practices

Duane Morris LLP
Duane Morris LLP
Contributor
Explore more from Duane Morris LLP

The Federal Trade Commission has reached a settlement with Caremark Rx LLC and Zinc Health Services LLC requiring structural changes to pharmaceutical pricing and reimbursement practices. This landmark agreement with one of the nation's three largest pharmacy benefit managers creates new compliance obligations and potential risks for stakeholders throughout the pharmaceutical supply chain.

United StatesConsumer Protection

On July 14, 2026, the Federal Trade Commission (FTC) announced a settlement with Caremark Rx LLC and Zinc Health Services LLC (together, Caremark) in the agency’s administrative case against the nation’s three largest pharmacy benefit managers (PBMs). Under the terms of the settlement, Caremark agreed to make certain structural changes to its pharmaceutical pricing and reimbursement practices. The FTC estimates the Caremark settlement will “lock in” up to $8.5 billion in consumer savings over the next 10 years and “unlock” as much as an additional $4.5 billion in savings from point-of-sale rebates over the same period.

Key Takeaways

  • The Caremark settlement reflects a significant antitrust enforcement action targeting vertical integration and exclusionary conduct in the healthcare industry, signaling increased regulatory scrutiny of practices that may foreclose competition in pharmaceutical distribution channels.

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

Disclaimer: This Alert has been prepared and published for informational purposes only and is not offered, nor should be construed, as legal advice. For more information, please see the firm's full disclaimer.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

See more popular content from